Sanofi India Share Price
Sanofi India Share Price Today
As of 5 Jul 2026, Sanofi India share price is ₹3,430.00. The stock opened at ₹3,464.60, compared to its previous close of ₹3,474.20. During today's trading session, Sanofi India share price moved in the range of ₹3,410.00 to ₹3,485.20, with an average price of ₹3,447.60 for the day. Looking at its last 52-week, the stock has touched a low of ₹3,054.00 and a high of ₹6,085.50. On the performance front, Sanofi India share price has declined by 17.31% over the last six months and is down 43.82% on a year-on-year basis.
Sanofi India Returns Calculator
Sanofi India Shareholder Returns
Sanofi India Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Sanofi India Financials
Income Statement · Consolidated
| Particulars | Dec 2024 | Dec 2023 |
|---|---|---|
| Revenue | ₹2,013.20 | ₹1,996.10 |
| Other Income | ₹16.50 | ₹61.20 |
| Total Revenue | ₹2,029.70 | ₹2,057.30 |
| Total Expenses | ₹1,560.60 | ₹1,546.60 |
| Profit Before Tax | ₹431.40 | ₹528.50 |
| Tax | ₹117.70 | ₹163.90 |
| Profit After Tax | ₹313.70 | ₹364.60 |
| EPS - Basic | ₹179.46 | ₹261.78 |
| EPS - Diluted | ₹179.46 | ₹261.78 |
Cash Flow · Consolidated
| Particulars | Dec 2024 | Dec 2023 |
|---|---|---|
| Profit before tax | ₹562.40 | ₹845.50 |
| Income before WC changes | ₹587.50 | ₹820.70 |
| Change in Assets | -₹186.60 | -₹241.80 |
| Change in Liabilities | ₹158.00 | -₹107.20 |
| Change in WC | -₹28.60 | -₹349.00 |
| Cash flow from Operations | ₹461.50 | ₹230.40 |
| Cash flow from Investing | -₹19.20 | ₹37.50 |
| Cash flow from Financing | -₹392.40 | -₹878.30 |
| Total Cash Flow | ₹49.90 | -₹610.40 |
| Cash (Start of the year) | ₹394.50 | ₹1,004.90 |
| Cash (End of the year) | ₹283.80 | ₹394.50 |
Balance Sheet · Consolidated
| Particulars | Dec 2024 | Dec 2023 |
|---|---|---|
| Non-Current Assets | ₹485.00 | ₹466.80 |
| Current Assets | ₹1,126.80 | ₹1,248.00 |
| Total Assets | ₹1,611.80 | ₹1,714.80 |
| Current Liabilities | ₹719.20 | ₹651.30 |
| Net Current Asset | ₹407.60 | ₹596.70 |
| Non-Current Liabilities | ₹32.00 | ₹48.30 |
| Equity Capital | ₹860.60 | ₹1,015.20 |
| Total Equity & Liabilities | ₹1,611.80 | ₹1,714.80 |
Income Statement · Standalone
| Particulars | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Revenue | ₹1,837.40 | ₹2,013.20 | ₹2,851.10 | ₹2,770.10 |
| Other Income | ₹19.70 | ₹16.50 | ₹65.30 | ₹71.50 |
| Total Revenue | ₹1,857.10 | ₹2,029.70 | ₹2,916.40 | ₹2,841.60 |
| Total Expenses | ₹1,385.10 | ₹1,560.60 | ₹2,088.40 | ₹2,109.30 |
| Profit Before Tax | ₹444.70 | ₹431.40 | ₹845.80 | ₹864.30 |
| Tax | ₹118.00 | ₹117.70 | ₹242.60 | ₹243.70 |
| Profit After Tax | ₹326.70 | ₹313.70 | ₹603.20 | ₹620.60 |
| EPS - Basic | ₹141.85 | ₹179.54 | ₹261.91 | ₹269.47 |
| EPS - Diluted | ₹141.85 | ₹179.54 | ₹261.91 | ₹269.47 |
Cash Flow · Standalone
| Particulars | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Profit before tax | ₹444.70 | ₹562.60 | ₹845.80 | ₹864.30 |
| Income before WC changes | ₹473.50 | ₹587.70 | ₹821.00 | ₹705.00 |
| Change in Assets | ₹310.90 | -₹186.60 | -₹241.70 | -₹16.50 |
| Change in Liabilities | -₹239.30 | ₹158.00 | -₹107.20 | -₹29.10 |
| Change in WC | ₹71.60 | -₹28.60 | -₹348.90 | -₹45.60 |
| Cash flow from Operations | ₹438.30 | ₹461.70 | ₹230.80 | ₹398.70 |
| Cash flow from Investing | -₹11.30 | -₹19.20 | ₹35.50 | ₹650.90 |
| Cash flow from Financing | -₹447.90 | -₹392.40 | -₹878.30 | -₹1,582.70 |
| Total Cash Flow | -₹20.90 | ₹50.10 | -₹612.00 | -₹533.10 |
| Cash (Start of the year) | ₹283.80 | ₹392.90 | ₹1,004.90 | ₹1,538.00 |
| Cash (End of the year) | ₹262.90 | ₹283.80 | ₹392.90 | ₹1,004.90 |
Balance Sheet · Standalone
| Particulars | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹454.20 | ₹485.00 | ₹468.80 | ₹461.40 |
| Current Assets | ₹800.60 | ₹1,126.80 | ₹1,246.30 | ₹1,610.30 |
| Total Assets | ₹1,254.80 | ₹1,611.80 | ₹1,715.10 | ₹2,071.70 |
| Current Liabilities | ₹491.40 | ₹736.50 | ₹651.30 | ₹740.60 |
| Net Current Asset | ₹309.20 | ₹390.30 | ₹595.00 | ₹869.70 |
| Non-Current Liabilities | ₹14.20 | ₹14.70 | ₹48.30 | ₹55.30 |
| Equity Capital | ₹749.20 | ₹860.60 | ₹1,015.50 | ₹1,275.80 |
| Total Equity & Liabilities | ₹1,254.80 | ₹1,611.80 | ₹1,715.10 | ₹2,071.70 |
About Sanofi India
Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company produces pharmaceutical formulations, dosage forms and offer a range of medicines across various therapeutic areas. Its product portfolio is focused on five therapeutic areas: diabetes, epilepsy, cardiology, allergy and pain care. In the diabetes area, the Company has an insulin portfolio under the brand name of Lantus, which helps in controlling high blood sugar in adults and children with diabetes mellitus. It also provides Toustar pen, along with dedicated Toujeo cartridges, addressing the need for a reusable delivery device. Combiflam, its product, helps to reduce pain and inflammation in conditions like headache, muscle and joint pain, and also reduces fever. Its brands also include Cardace, Allegra, Avil and Frisium. The Company has its own manufacturing facility in Goa. It has around 12 contract manufacturing organizations.
Sanofi India Financial Highlights
- Revenue: Sanofi India reported revenue of ₹2,029.70 crore in FY24 vs ₹2,057.30 crore in FY23. It showed a decrease of 1.34% on a yearly basis.
- Operating Profit: Sanofi India reported an operating profit of ₹431.40 crore in FY24 vs ₹528.50 crore in FY23. It showed a decrease of 18.37% on a year-on-year basis.
- Net Profit: Sanofi India reported a net profit of ₹413.30 crore in FY24 vs ₹602.90 crore in FY23. It showed a decrease of 31.45% on a yearly basis.
Sanofi India Quarterly Result Highlights
- Sanofi India reported revenue of ₹520.80 crore in Dec 2024, compared with ₹526.30 crore in Sep 2024, representing a decrease of 1.05% on a quarter-on-quarter (QoQ) basis.
- Sanofi India reported an operating profit of ₹122.20 crore in Dec 2024, compared with ₹112.60 crore in Sep 2024, representing an increase of 8.53% on a quarter-on-quarter (QoQ) basis.
- Sanofi India reported a profit of ₹91.30 crore in Dec 2024, compared with ₹82.20 crore in Sep 2024, reflecting an increase of 11.07% on a QoQ basis.
- The earnings per share (EPS) of Sanofi India stood at ₹179.46 during Dec 2024.
Similar Stocks
FAQs on Sanofi India Share Price
What is Sanofi India share price today?
Sanofi India share price is ₹3,430.00 as on 03 Jul, 2026, 15:29 IST.
How has the Sanofi India share price performed in the past?
In the last 1 year, Sanofi India delivered a return of -43.82%. The Sanofi India share price hit a high of ₹6,085.50 and low of ₹3,054.00.
How much is the Mutual Fund shareholding in Sanofi India shares?
The Mutual Fund Shareholding in Sanofi India was 9.26% at the end of Mar 2026.
What is the the 52-week high and low of Sanofi India shares ?
The 52-week high and low of Sanofi India share is ₹6,085.50 and ₹3,054.00 as of 03 Jul, 2026.
What is the market cap of Sanofi India?
The market capitalisation of Sanofi India is ₹8,111.74 Crores as on 03 Jul, 2026.
What are the stock symbols of Sanofi India?
The stock symbol of Sanofi India is SANOFI on the NSE, 500674 on the BSE, and the ISIN is INE058A01010.
What was yesterday's closing price of Sanofi India shares ?
Sanofi India shares closed yesterday at ₹3,474.20 on NSE & ₹3,476.10 on BSE
How to buy Sanofi India shares?
To buy Sanofi India shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Sanofi India shares on Holidays?
No, shares of Sanofi India or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Sanofi India shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Sanofi India?
The PE and PB ratio of Sanofi India is 34.06 and 16.36 respectively, as on 03 Jul, 2026, 15:29 IST.